0.05Open0.05Pre Close0 Volume329 Open Interest2.50Strike Price0.00Turnover196.96%IV62.42%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1739Delta0.4031Gamma31.40Leverage Ratio-0.0053Theta0.0001Rho5.46Eff Leverage0.0008Vega
Fortress Biotech Stock Discussion
- SEC Filing
Fortress Biotech Inc: FDA Accepted Nda Filing for Dfd-29 to Treat Inflammatory Lesions & Erythema of Rosacea in Adults; Pdufa Goal Date of Nov 4, 2024
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
$OptiNose (OPTN.US)$
when are the next date for $Checkpoint Therapeutics (CKPT.US)$ , $Fortress Biotech (FBIO.US)$ , and $Brainstorm Cell Therapeutics (BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
No comment yet